Tradfi
Sectors
Sentiment
Bitcoin vs Johnson & Johnson — digital scarce asset vs AAA-rated healthcare Dividend Aristocrat.
| Metric | Bitcoin | Johnson & Johnson | Δ |
|---|---|---|---|
| Bitcoin Market Cap | $1.56T | — | — |
| Bitcoin Price | $77.86K | — | — |
| Bitcoin 24h Change | -0.22% | — | — |
| Bitcoin FDV | $1.56T | — | +0.0% |
| Bitcoin ATH | $126.08K | — | — |
Crypto data live from Sharpe's tracker cache; TradFi values are reference benchmarks updated quarterly.
Johnson & Johnson's market cap has ranged $370B-$430B in 2024-2026, anchored by pharmaceuticals, medtech, and legacy consumer-health (spun off as Kenvue). Bitcoin's market cap ($1T-$2.5T) is 2-7x J&J. J&J has $85B+ in annual revenue, a AAA-rated balance sheet, and a 60+ year dividend increase streak — the 'safest' megacap equity in US healthcare. Bitcoin sits at the opposite end of the risk spectrum: high volatility, no cash flows, no operating business. The contrast is the purest in this file — Dividend Aristocrat vs purely-speculative digital scarce asset. Correlation near zero.
Side-by-side crypto comparison with normalized returns
Rolling correlation between crypto and major TradFi benchmarks